Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 14:8:670370.
doi: 10.3389/fmed.2021.670370. eCollection 2021.

Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination

Affiliations

Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination

Gang Lv et al. Front Med (Lausanne). .

Abstract

Background: The emergency use authorization for coronavirus disease 2019 (COVID-19) vaccines brought both hopes and concerns to the Americans and others. We aimed to estimate the mortality rate of COVID-19 vaccination and presented characteristics of deaths following COVID-19 vaccination. Methods: Data on deaths following COVID-19 vaccination were obtained from the Vaccine Adverse Event Reporting System (VAERS) from December 11, 2020 through January 8, 2021. The Centers for Disease Control and Prevention (CDC) COVID Data Tracker was used to identify the total number of people receiving COVID-19 vaccines during the same period to estimate the mortality rate. Stratified analysis was conducted by the location of vaccination. Results: As of January 8, 2021, 55 deaths were reported, and the mortality rate of COVID-19 vaccination was 8.2 per million population. A total of 37 deaths were reported among long-term care facility residents, and the mortality rate was 53.4 per million population. Top reported comorbidities associated with deaths included hypertension, dementia, chronic obstructive pulmonary disease (COPD), diabetes, and heart failure. In addition, dementia was more likely to be associated with deaths vaccinated at long-term care facilities than at other locations. Conclusion: The benefits of COVID-19 vaccines outweigh the potential risks in older frail populations, and our findings do not support actions to exclude older adults from being vaccinated. However, continued monitoring of COVID-19 vaccination is still warranted.

Keywords: COVID-19; long-term care facility; pharmacovigilance; safety; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Torjesen J. Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination. BMJ. (2021) 372: n149. 10.1136/bmj.n149 - DOI - PubMed
    1. Andrew MK, McElhaney JE. Age and frailty in COVID-19 vaccine development. Lancet. (2021) 396:1942–4. 10.1016/S0140-6736(20)32481-8 - DOI - PMC - PubMed
    1. Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine. (2015) 33:4398–405. 10.1016/j.vaccine.2015.07.035 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . CDC COVID Data Tracker. (2021). Available online at: https://covid.cdc.gov/covid/data/tracker/#vaccinations (accessed January 16, 2021).
    1. Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. JAMA. (2021) 325:780–1. 10.1001/jama.2021.0600 - DOI - PMC - PubMed